Keyword: Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham researchers sensitized melanoma to PD-1 blockade by inhibiting a protein called Siah2 in mouse models of the disease.
The week’s biotech news included one stem-cell-derived treatment for diabetes and another for regrowing hair.
Sanford Burnham Prebys scientists found that some pancreatic cells can dial up a nutrient support route using available glutamine.
Two research groups have uncovered clues to immuno-oncology drug resistance, offering insight that could lead to new treatment strategies.
Blocking a pathway that causes healing cells to turn bad could offer a new way to treat neurological disorders.
A Stanford team aimed at host cells to fight flaviviruses, while Harvard scientists examined the longevity of Zika vaccines.
Biotech news over the last week included a reversible sealant to shore up eye injuries and a promising gene therapy for the immune disorder known as "bubble boy" disease.
The past week brought new insights into how beige fat cells burn glucose, a particular protein foretells Alzheimer's and bacteria evade antibiotics.
Two sets of researchers announced progress this week advancing research aimed at targeting addiction centers in the brain.
Protein signaling in adipose tissue could play a broad role in preventing obesity and diabetes, Sanford Burnham researchers have found.